Table 2 Clinical characteristics of the GSE39582 (OS.time ≤ 80).
GSE39582 | |
|---|---|
Cases | 394 |
Age (median, range) | 69 (22–97) |
Gender | |
Female | 170 (43.15%) |
Male | 224 (56.85%) |
T stage | |
T1 | 7 (1.78%) |
T2 | 35 (8.88%) |
T3 | 255 (64.72%) |
T4 | 97 (24.62%) |
N stage | |
N0 | 207 (52.54%) |
N1 | 99 (25.13%) |
N2 | 88 (22.34%) |
M stage | |
M0 | 337 (85.53%) |
M1 | 57 (14.47%) |
MMR status | |
pMMR | 310 (78.68%) |
dMMR | 60 (15.23%) |
NA | 24 (6.09%) |
Survival status | |
Alive | 235 (59.64%) |
Dead | 159 (40.36%) |